Pricing Log in Create free account
Friday 6 November 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.

Revenue
+41.2%
EPS
−3.67%
Free cash flow
+79.0%

Quarter to September 2026, against a year earlier

160.47 5.58 −3.36%
Market cap
$16.2B
P/E
23.0×
Fwd P/E
20.6×
Dividend yield
—
F-score
7/9
Altman Z
7.80
Beneish M
−2.64
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Neurocrine Biosciences, Inc. (NBIX) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Neurocrine Biosciences, Inc. (NBIX) trades at a EV/FCF of 15.5×. Over the past ten years it has ranged from −150× (June 2018) to 18,307× (April 2019); the current reading is higher than 31% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 17.6× (25.56%)
FY2024 23.7× (30.97%)
FY2023 34.3× 0.67%
FY2022 34.0× (1.61%)
FY2021 34.6× (14.69%)
FY2020 40.6× (44.38%)
FY2019 72.9× (14.89%)
FY2018 85.7× —
FY2017 −67.5× —
FY2016 −27.6× —

Quarterly newest first

Period EV/FCF Change
Sep 2026 13.7× (30.70%)
Jun 2026 19.7× 31.55%
Mar 2026 15.0× (14.77%)
Dec 2025 17.6× (22.01%)
36 more quarters

Against its own ten years

Low −150× High 18,307×
Ten-year median 26.2×
Current reading's percentile 2

EV/FCF against peers

Company EV/FCF
HLN Haleon PLC Sponsored ADR compare 11.4×
NBIX Neurocrine Biosciences, Inc. 15.5×
VTRS Viatris Inc. compare 16.3×
ZTS Zoetis Inc. compare 18.4×
UTHR United Therapeutics Corporation compare 24.2×
KNSA Kiniksa Pharmaceuticals International, plc compare 32.2×
ALKS Alkermes plc compare 36.0×
ELAN Elanco Animal Health Incorporated compare 42.7×
RDY Dr. Reddy's Laboratories Ltd compare 126×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on NBIX